Replies to post #40845 on Ocata Therapeutics Inc fka OCAT

[rocky301]

north,

phase 2 was already approved when ACT bought Mytogen in 2007. Clinical trial info is now over 4 years old. Dead horse, imo.
http://clinicaltrials.gov/ct2/show/NCT00626314